Susquehanna International Group, LLP Clearside Biomedical, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,169 shares of CLSD stock, worth $26,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,169

Previous 59,038 43.82%

Holding current value

$26,203

Previous $59,000 49.15%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.79 - $1.13 $20,436 - $29,231	-25,869 Reduced 43.82%	33,169 $30,000
Q4 2024 Feb 14, 2025	BUY	$0.87 - $1.58 $33,685 - $61,176	38,719 Added 190.56%	59,038 $59,000
Q3 2024 Nov 14, 2024	BUY	$0.93 - $1.35 $18,896 - $27,430	20,319 New	20,319 $25,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.18 $21,141 - $36,687	31,091 Added 52.69%	90,093 $105,000
Q3 2023 Nov 14, 2023	BUY	$0.82 - $1.27 $17,762 - $27,510	21,662 Added 58.01%	59,002 $51,000
Q2 2023 Aug 11, 2023	BUY	$0.97 - $1.48 $1,121 - $1,710	1,156 Added 3.19%	37,340 $41,000
Q1 2023 May 16, 2023	BUY	$0.93 - $1.66 $15,419 - $27,522	16,580 Added 84.57%	36,184 $37,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $116,415 - $174,622	-116,415 Reduced 85.59%	19,604 $21,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $33,902 - $57,445	-31,391 Reduced 18.75%	136,019 $154,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.49 $82,643 - $158,294	63,572 Added 61.22%	167,410 $246,000
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $233,566 - $498,274	-173,012 Reduced 62.49%	103,838 $238,000
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $271,888 - $571,765	-99,959 Reduced 26.53%	276,850 $761,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $1.64 Million - $2.44 Million	339,054 Added 898.04%	376,809 $2.26 Million
Q2 2021 Aug 11, 2021	SELL	$2.32 - $5.38 $248,993 - $577,408	-107,325 Reduced 73.98%	37,755 $184,000
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $264,147 - $501,172	117,923 Added 434.23%	145,080 $358,000
Q4 2020 Feb 16, 2021	BUY	$1.32 - $2.74 $4,795 - $9,954	3,633 Added 15.44%	27,157 $74,000
Q3 2020 Nov 16, 2020	SELL	$1.45 - $2.0 $112,894 - $155,716	-77,858 Reduced 76.8%	23,524 $36,000
Q2 2020 Aug 14, 2020	SELL	$1.55 - $2.41 $720,582 - $1.12 Million	-464,892 Reduced 82.1%	101,382 $191,000
Q1 2020 May 15, 2020	BUY	$1.32 - $3.77 $338,598 - $967,057	256,514 Added 82.81%	566,274 $963,000
Q4 2019 Feb 14, 2020	BUY	$0.62 - $3.4 $177,964 - $975,932	287,039 Added 1263.32%	309,760 $898,000
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $137,007 - $255,384	22,721 New	22,721 $140,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

11M

Call Options Held

5.9K

Put Options Held

86.6K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $47.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Clearside Biomedical, Inc. Transaction History